A month after a report by a committee appointed by the National Academy of Sciences, at the request of the Justice Department, concluded that the scientific evidence implicating Bruce Ivins to the anthrax letter attacks was not definitive,The Los Angeles Times reports . . . Continue reading →
The authoritative expert who chaired the DSM-IV revision has become a formidable critic whose publicly expressed views about psychiatry’s diagnostic assessments and prescribed treatments–mostly chemical interventions–validate the criticism expressed by the Alliance for Human Research Protection for more than a dozen years. Continue reading →
If mentally incapacitated troops are being drugged with dangerous, mind-altering drugs and deployed to battle against their will, how can we say that we have a volunteer army?
"For her last month of life, Kifuji overall prescribed 835 pills to Rebecca….If what Dr. Kifuji did in this case is the acceptable standard of care for children in Massachusetts, then there is something very wrong in this state."
The Obama Administration opposes a proposed independent probe by the Inspector General of the anthrax-laced letter attacks, arguing that it would "undermine public confidence” in a Federal Bureau of Investigation probe of the attacks “and unfairly cast doubt on its conclusions.”
Continue reading →
Who is accountable for the chemical torture of children who were subjected to medical maltreatment that borders on criminal negligence?
Continue reading →
America’s profit-driven medical paradigm overdiagnoses illness and garners profits from unnecessary treatment. Continue reading →
Unless the overall treatment and services provided to schizophrenia patients in Finland is unique and especially protective—which the authors do not suggest—their claimed findings of lowered mortality rates for antipsychotic drug users are belied by a consistent body of evidence.
Among the most damaging scientific evidence against the use of antipsychotic drugs is empirical evidence that they cause brain damage. Continue reading →
The FDA’s expanded marketing approval process for antipsychotics, highly toxic drugs, is unaffected by evidence uncovered by the US Justice Department showing that the studies submitted by drug manufacturers were often flawed, if not fraudulent. Continue reading →
"The story’s pretty clear, and pretty embarrassing for the profession of psychiatry, which has allowed itself to be led by marketing," says Dr. Robert Rosenheck, Yale. Continue reading →